| Farmax Retail (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 02, 2009, inter alia, has considered and approved the following:
1. Increase of Authorized Capital from Rs. 14 Crores to Rs. 50 Crores.
2. Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each.
3. Raising monies up to INR 500 Crores by issue of FCCBs/GDRs/FPO/QIPs in accordance with the provisions of all applicable laws.
4. Convening EGM of the shareholders on January 01, 2010 for the above matters.
Farmax Retail (India) Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the Company will be held on January 01, 2010.inter alia, to transact the following items of business:
1. Increase of Authorized Share Capital:
- To increase the Authorized Share Capital of the Company from Rs. 14,00,00,000/- (Rupees Fourteen Crores Only) divided into 1,40,00,000 (One Crore Forty Lakhs) equity shares of Rs. 10/- (Rupees Ten Only) each to Rs. 50,00,00,000/- (Rupees Fifty Crores Only) divided into 5,00,00,000 (Five Crores) equity shares of Rs. 10/- (Rupees Ten Only) each, ranking pari passu with the existing equity shares & consequential amendment in the Memorandum of Association of the Company.
2. Sub-division of the Face Value of Equity Shares:
- For sub-division of each of the existing issued equity shares of Rs. 10/- (Rupees Ten Only) each in the issued, subscribed and paid-up capital of the Company into 2 (Two) equity shares of the face value of Rs. 5/- (Rupees Five Only) each fully paid up consequential amendment in the Memorandum and Articles of Association pertaining to the Share Capital of the Company be accordingly altered.
3. To raise monies on preferential basis:
- To offer, issue and allot (including with provisions for reservation on firm and / or competitive basis, of such part of issue and for such categories of persons including employees of the Company as may be permitted) either in India or in the course of international offering(s) in one or more foreign markers, such number of Equity Shares with or without a green shoe option. Global Depository Receipts (GDRs), in registered or bearer form, Foreign Currency Convertible Bonds (FCCBs), Qualified Institutional Placement (as defined by the SEBI (DIP) Guidelines, 2000) pursuant to a Qualified Institutions Placements, as provided under Chapter XIIIA of the SEBI DIP Guidelines (QIP) and / or securities with or without detachable warrants with right exercisable by the warrant holders to convert or subscribe to Equity Shares (all of which are hereinafter collectively referred to as Securities) or any combination of Securities, in one or more tranches, whether rupee denominated or denominated in foreign currency, to any eligible person, including foreign / resident invertors (whether institutions, incorporated bodies, mutual funds, individuals or otherwise), Foreign Institutional Investors, Indian and / or Multilateral Financial Institutions, Mutual Funds, Non-Resident Indians, stabilizing agents, and / or any other categories of investors, whether they be holders of shares of the Company or not (collectively called the Investors) through public issue(s) of prospectus in India or outside India, a qualified institutional placement, a rights offering, private placements(s) in India or outside India, or a combination thereof at such time or times, at such price or prices, at a discount or premium to market price or prices in such manner and on such terms and conditions as may be deemed appropriate by the Board at its absolute discretion including the discretion to determine the categories of Investors to whom the offer, issue and allotment shall be made to the exclusion of all other categories of Investors at the time of such offer, issue and allotment considering the prevailing market conditions and other relevant factors and wherever necessary in consultation with Lead Managers, up to an amount not exceeding Rs. 500 Crores (Rupees Five Hundred Crores Only) either in foreign currency or Indian Rupees inclusive of such premium as may be determined by the Board, in any convertible foreign currency, as the Board at its absolute discretion may deem fit and appropriate, subject to necessary provisions & approvals.
(As Per BSE Announcement Dated on 30/12/2009)
Farmax Retail (India) Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on January 01, 2010, inter alia, have approved the following:
1. Increase ofAuthorized Capital from Rs. 14 Crores to Rs. 50 Crores.
2. Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each.
3. Raising monies up to INR 500 Crores by issue of FCCBs/GDRs/FPO/QIPs in accordance with the provisions of all applicable laws.
(As Per BSE Announcement Dated on 04/01/2010) |